News
New Lancet Rheumatology paper shows low risk of severe outcomes from Rituximab use for patients who receive COVID and Booster vaccination
Patients taking an immunosuppressant drug for rheumatic and musculoskeletal diseases do not appear to be at higher risk of serious outcomes from COVID-19 infection as long as they are vaccinated.
Impressive results with long COVID pacing trial
A pacing rehabilitation programme that helps people with long COVID reduce their symptoms and increase activity levels has shown “impressive” results, say scientists.
One in five GPs unwilling to prescribe aspirin to people at risk of bowel cancer
One in five GPs could be unwilling to prescribe aspirin to patients with a cancer-causing syndrome, despite national guidelines advising it, new research has found.
New study shows viral contamination reduced with hand drying
Leeds researchers explored whether act of hand drying, and the method used, could lead to formation of aerosols
Preventing European cancer epidemic
Europe will face a cancer epidemic in the next decade if weaknesses in cancer health systems and cancer research are not urgently addressed, say the authors of a major new report.